Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05019664 · ClinicalTrials.gov registry record

Affixus Natural Nail System Humeral Nail PMCF

A clinical trial of Humeral Fractures and Humeral Fractures, Proximal, sponsored by Zimmer Biomet.

Recruiting
Registry status
100
Enrollment target
5
Study locations

NCT05019664: Recruiting study of Humeral Fractures and Humeral Fractures, Proximal, sponsored by Zimmer Biomet.

NCT05019664 is a study of Humeral Fractures and Humeral Fractures, Proximal that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 100 participants. The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05019664, a study of Humeral Fractures and Humeral Fractures, Proximal, is actively recruiting participants, sponsored by Zimmer Biomet.

RECRUITING
Registry status
100 participants
Enrollment target
5
Study locations

Study Summary

A commercially available product clinical study which aims to confirm the safety, performance and clinical benefits to the patient of the Affixus Natural Nail upper arm (humerus) bone nail system for both the implant itself and the instrumentation used during surgery.

Primary Outcome

The primary endpoint is bone union after 12 months since surgery. (Bone union defined as no pain or tenderness at the site, and strong enough to allow normal activities.)

Interventions

  • DEVICE humeral fracture

Study Locations (5)

Other

  • UZ Leuven - Traumatology Department - Leuven
  • Hospital de la Santa Creu i Sant Pau - Barcelona
  • General Foundation of the University of Valladolid - Valladolid

Texas

  • University of Texas Health Science Center at San Antonio - San Antonio

Thurgau

  • Kantonsspital Frauenfeld - Frauenfeld

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-08-29
Est. Completion 2027-08
Zimmer Biomet

115 total trials

What NCT05019664 shows while recruiting

NCT05019664 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 2 conditions, with Humeral Fractures appearing as the primary indexed condition, and to 1 intervention - of which humeral fracture is the first listed.

NCT05019664 lists 5 locations in 3 states (Other, Texas, Thurgau).

Frequently Asked Questions

What is clinical trial NCT05019664 about?

NCT05019664 is a clinical study titled "Affixus Natural Nail System Humeral Nail PMCF". A commercially available product clinical study which aims to confirm the safety, performance and clinical benefits to the patient of the Affixus Natural Nail upper arm (humerus) bone nail system for both the implant itself and the instrumentation used during surgery.

What is the current status of trial NCT05019664?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-08-29. Estimated completion is 2027-08.

What conditions does trial NCT05019664 study?

This clinical trial studies the following conditions: Humeral Fractures, Humeral Fractures, Proximal.

What interventions are being tested in trial NCT05019664?

The interventions under investigation include: humeral fracture (DEVICE).

Who is sponsoring clinical trial NCT05019664?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05019664 being conducted?

This trial has 5 study locations across Texas, Thurgau. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Humeral Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05019664, the US trial registry maintained by the National Library of Medicine. NCT05019664 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.